12:00 AM
 | 
Oct 22, 2012
 |  BC Week In Review  |  Company News  |  Other News

Pfenex, National Institutes of Health, U.S. Department of Health and Human Services infectious, drug delivery news

NIH's National Institute of Allergy and Infectious Diseases (NIAID) awarded Pfenex a contract worth up to $22.9 million for up to five years to develop a dry formulation of its recombinant protective antigen (

Read the full 151 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >